Peer review reports
From: Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study
Original Submission |
14 Mar 2016 |
Submitted |
Original manuscript
|
|
Author responded |
Author comments
|
|
Reviewed |
Reviewer Report
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
|
Author responded |
Author comments
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Publishing |
28 Jun 2016 |
Editorially accepted |
|
13 Jul 2016 |
Article published |
10.1186/s12885-016-2491-y
|
Learn about peer review